University of Erlangen-Nürnberg — CureCurrent

How to interpret these research links

Connected source records

The exact organization name University of Erlangen-Nürnberg appears in 15 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials15

Recruiting shown0

Roles2

SourceClinicalTrials.gov

Clinical trials

15 shown

Facilitating Motor Skill Learning in Parkinson's Disease IIINCT04653285 · lead sponsor · 2022-07-01

Internet-based Rehabilitation Aftercare Focusing on Physical Activity Promotion in Persons With COPDNCT05006560 · lead sponsor · 2021-07-05

Internet-based Physical Activity Promotion and Exercise Prescription for People With Multiple SclerosisNCT04367389 · lead sponsor · 2019-10-01

Internet-based Physical Activity Promotion and Exercise Prescription for People With Multiple Sclerosis (Feasibility Study)NCT04057066 · lead sponsor · 2019-02-28

Facilitating Motor Skill Learning in Parkinson's Disease II (FaST-PD II)NCT03886090 · lead sponsor · 2019-01-01

Validation of a Smartwatch in Persons With Multiple SclerosisNCT03750097 · lead sponsor · 2018-05-01

Facilitating Motor Skill Learning in Parkinson's DiseaseNCT03245216 · lead sponsor · 2017-03-01

Pedometer-based Behavioural Intervention for Individuals With COPD to Stay Active After RehabilitationNCT02966561 · lead sponsor · 2016-06-01

Internet-based MOTOmed Exercise to Reduce Spasticity and Improve Physical Function in Persons With Multiple SclerosisNCT03548974 · lead sponsor · 2015-01-01

Stability and Balance in Locomotion Through ExerciseNCT01856244 · lead sponsor · 2013-06-01

Effect of an Internet-based At-home Physical Training Protocol on Quality of Life, Fatigue, Functional Performance, Aerobic Capacity and Muscle Strength in Multiple Sclerosis PatientsNCT02771652 · lead sponsor · 2010-02-01

Contrast Sensitivity in GlaucomaNCT00947869 · lead sponsor · 2009-04-01

Breath Test to Predict Breast Cancer and Outcome of MammographyNCT04755829 · collaborator · 2021-03-01

Effects of Whole-body Electromyostimulation and Dietary Supplements on "Sarcopenic Obesity"NCT02356016 · collaborator · 2013-08-01

Bupropion for the Treatment of Apathy in Alzheimer's DementiaNCT01047254 · collaborator · 2010-01-01

Drugs studied in this sponsor's trials

0 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing University of Erlangen-Nürnberg as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

No mapped drug interventions are published for this sponsor's trials. This does not mean the studies contain no drug interventions: some registry names have not been mapped to RxNorm.

Sponsor roles

lead sponsor12

collaborator3

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.